<HashMap><database>NODE</database><scores/><additional><omics_type>Transcriptomics</omics_type><submitter>Jianfeng Li</submitter><technology_type>RNA-Seq</technology_type><disease>['acute Myeloid Leukemia']</disease><full_dataset_link>https://www.biosino.org/node/experiment/detail/OEX00014476</full_dataset_link><experiment_platform>Illumina NovaSeq 6000</experiment_platform><experiment_library_layout>Paired</experiment_library_layout><experiment_library_selection>Inverse rRNA</experiment_library_selection><sample_count>103</sample_count><tissue>['bone Marrow']</tissue><taxonomy>['Homo sapiens']</taxonomy><experiment_protocol>Total RNA was extracted using the AllPrep DNA/RNA Mini Kit (Qiagen) or TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. The quality and quantity of RNA were respectively evaluated by the Agilent 2100 Bioanalyzer system (Agilent Technologies) and Qubit (Life Technologies) before library preparation. Libraries for RNA-Seq from ZIH (n = 103) were prepared utilizing the KAPA RNA HyperPrep Kit with RiboErase (Roche), and were sequenced on a NovaSeq 6000 platform (Illumina).</experiment_protocol><repository>NODE</repository></additional><is_claimable>false</is_claimable><name>AML_ZIH_BM_RNA</name><description>Total RNA was extracted from bone marrow mononuclear cells of patients diagnosed with acute myeloid leukemia in Zhejiang Institute of Hematology (ZIH, n = 103), and then was subjected to ribosomal-removed RNA sequencing (RNA-Seq).</description><dates><publication>2022-07-07</publication><submission>2021-09-06</submission></dates><accession>OEX00014476</accession><cross_references><NODE>OEP00002686</NODE></cross_references></HashMap>